Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ridloff Elena Insider Profile
4 Followers
Ridloff Elena, EVP & CFO at ACADIA Pharmaceuticals, holds 2.63K shares in Kronos Bio (Ticker: KRON), holds 2.19K shares in ACADIA Pharmaceuticals (Ticker: ACAD). Most recently, Ridloff Elena Bought ― shares of Kronos Bio on Oct 16, 2020 for an estimated value of 49.97K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-8.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ridloff Elena holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ridloff Elena
Ridloff Elena's Trading History
ACADIA Pharmaceuticals
May 01, 2020
EVP & CFO
Uninformative Sell
507.30K
$122.92K
Kronos Bio
Oct 16, 2020
Director
Informative Buy
49.97K
$91.21K
List of latest transactions for each holding click on a transaction to see Ridloff Elena's performance on stock
You May Also Like
Ridloff Elena insider profile FAQ
What is the percentage of profitable transactions made by Ridloff Elena?
The percentage of profitable transactions made by Ridloff Elena is 50%.
What is the average return per transaction made by Ridloff Elena?
The average return per transaction made by Ridloff Elena is -8.20%.
What stocks does Ridloff Elena hold?
Ridloff Elena holds: ACAD, KRON stocks.
What was Ridloff Elena’s latest transaction?
Ridloff Elena latest transaction was an Informative Buy of $49.97K.
What was Ridloff Elena's most profitable transaction?
Ridloff Elena’s most profitable transaction was an Informative Buy of KRON stock on October 16, 2020. The return on the trade was 8.10%.
What is Ridloff Elena's role in ACADIA Pharmaceuticals?
Ridloff Elena's role in ACADIA Pharmaceuticals is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.